Health status in 1040 adults with disorders of sex development (DSD): a European multicenter study

Objective The knowledge about health status in adults with disorder of sex development (DSD) is scarce. Design and methods A cross-sectional observational study in 14 European tertiary centers recruited 1040 participants (717 females, 311 males, 12 others) with DSD. Mean age was 32.4 ± 13.6 year (range 16–75). The cohort was divided into: Turner (n = 301), Klinefelter (n = 224), XY-DSD (n = 222), XX-DSD (excluding congenital adrenal hyperplasia (CAH) and 46,XX males) (n = 21), 46,XX-CAH (n = 226) and 45,X/46,XY (n = 45). Perceived and objective health statuses were measured and compared to European control data. Results In DSD, fair to very good general health was reported by 91.4% and only 8.6% reported (very) bad general health (controls 94.0% and 6.0%, P < 0.0001). Longstanding health issues other than DSD and feeling limited in daily life were reported in 51.0% and 38.6%, respectively (controls 24.5% and 13.8%, P < 0.0001 both). Any disorder except DSD was present in 84.3% (controls 24.6%, P < 0.0001). Males reported worse health than females. In the subgroup analysis, Klinefelter and 46,XX-DSD patients reported bad general health in 15.7% and 16.7%, respectively (Turner 3.2% and CAH 7.4%). Comorbidities were prevalent in all DSD subgroups but Klinefelter and Turner were most affected. Early diagnosis of DSD and a healthy lifestyle were associated with less comorbidities. Conclusions Overall, general health appeared to be good but a number of medical problems were reported, especially in Klinefelter and Turner. Early diagnosis of DSD and a healthy lifestyle seemed to be important. Lifelong follow-up at specialized centers is necessary.

[1]  J. Słowikowska-Hilczer,et al.  Participation of adults with disorders/differences of sex development (DSD) in the clinical study dsd-LIFE: design, methodology, recruitment, data quality and study population , 2017, BMC Endocrine Disorders.

[2]  T. Kolon,et al.  Malignancy in disorders of sex development , 2016, Translational andrology and urology.

[3]  S. Colucci,et al.  Bone Fragility in Turner Syndrome: Mechanisms and Prevention Strategies , 2016, Front. Endocrinol..

[4]  H. Falhammar,et al.  CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY PRESENTING AS ADRENAL INCIDENTALOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS. , 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[5]  P. Lichtenstein,et al.  Congenital adrenal hyperplasia and risk for psychiatric disorders in girls and women born between 1915 and 2010: A total population study , 2015, Psychoneuroendocrinology.

[6]  H. Falhammar,et al.  Biochemical and genetic diagnosis of 21-hydroxylase deficiency , 2015, Endocrine.

[7]  H. Falhammar,et al.  Increased Cardiovascular and Metabolic Morbidity in Patients With 21-Hydroxylase Deficiency: A Swedish Population-Based National Cohort Study. , 2015, The Journal of clinical endocrinology and metabolism.

[8]  R. Auchus,et al.  Adrenal steroidogenesis and congenital adrenal hyperplasia. , 2015, Endocrinology and metabolism clinics of North America.

[9]  Jacques Young,et al.  Clinical Outcome, Hormonal Status, Gonadotrope Axis, and Testicular Function in 219 Adult Men Born With Classic 21-Hydroxylase Deficiency. A French National Survey. , 2015, The Journal of clinical endocrinology and metabolism.

[10]  P. Span,et al.  Molecular characterization of testicular adrenal rest tumors in congenital adrenal hyperplasia: lesions with both adrenocortical and Leydig cell features. , 2015, The Journal of clinical endocrinology and metabolism.

[11]  H. Falhammar,et al.  Increased mortality in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. , 2014, The Journal of clinical endocrinology and metabolism.

[12]  P. Lichtenstein,et al.  Increased psychiatric morbidity in men with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. , 2014, The Journal of clinical endocrinology and metabolism.

[13]  C. Gravholt,et al.  Clinical review: Klinefelter syndrome--a clinical update. , 2013, The Journal of clinical endocrinology and metabolism.

[14]  M. Nishitani,et al.  Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia. , 2012, The Journal of clinical endocrinology and metabolism.

[15]  C. Gravholt,et al.  Cardiovascular phenotype in Turner syndrome--integrating cardiology, genetics, and endocrinology. , 2012, Endocrine reviews.

[16]  J. Svartberg,et al.  Genetic, anthropometric and metabolic features of adult Norwegian patients with 21-hydroxylase deficiency. , 2012, European journal of endocrinology.

[17]  H. Falhammar,et al.  Fertility, sexuality and testicular adrenal rest tumors in adult males with congenital adrenal hyperplasia , 2011, European journal of endocrinology.

[18]  S. Rose,et al.  Description of children with 45,X/46,XY karyotype , 2012, European Journal of Pediatrics.

[19]  H. Falhammar,et al.  Clinical outcomes in the management of congenital adrenal hyperplasia , 2012, Endocrine.

[20]  S. Mora,et al.  Bone Health in Disorders of Sex Differentiation , 2010, Sexual Development.

[21]  J. Connell,et al.  Health Status of Adults with Congenital Adrenal Hyperplasia: A Cohort Study of 203 Patients , 2010, Journal of Clinical Endocrinology and Metabolism.

[22]  F. Beuschlein,et al.  Total adrenal volume but not testicular adrenal rest tumor volume is associated with hormonal control in patients with 21-hydroxylase deficiency. , 2010, The Journal of clinical endocrinology and metabolism.

[23]  H. Falhammar,et al.  Gender role behavior, sexuality, and psychosocial adaptation in women with congenital adrenal hyperplasia due to CYP21A2 deficiency. , 2009, The Journal of clinical endocrinology and metabolism.

[24]  G. Conway,et al.  Comparison of bone mineral density and body proportions between women with complete androgen insensitivity syndrome and women with gonadal dysgenesis. , 2008, European journal of endocrinology.

[25]  A. Swerdlow,et al.  Cancer incidence in women with Turner syndrome in Great Britain: a national cohort study. , 2008, The Lancet. Oncology.

[26]  H. Falhammar,et al.  Fractures and bone mineral density in adult women with 21-hydroxylase deficiency. , 2007, The Journal of clinical endocrinology and metabolism.

[27]  H. Falhammar,et al.  Metabolic profile and body composition in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. , 2007, The Journal of clinical endocrinology and metabolism.

[28]  C. Gravholt,et al.  Morbidity in Klinefelter syndrome: a Danish register study based on hospital discharge diagnoses. , 2006, The Journal of clinical endocrinology and metabolism.

[29]  S Faisal Ahmed,et al.  CONSENSUS STATEMENT ON MANAGEMENT OF INTERSEX DISORDERS. INTERNATIONAL CONSENSUS CONFERENCE ON INTERSEX ORGANIZED BY THE LAWSON WILKINS PEDIATRIC ENDOCRINE SOCIETY AND THE EUROPEAN SOCIETY FOR PAEDIATRIC ENDOCRINOLOGY , 2006 .